Parkwalk Advisors

Brainomix develops AI-powered imaging biomarkers for neurological and cerebrovascular disorders. Its software suite, including e-ASPECTS, e-CTA, and e-Mismatch, automates brain scan analysis to assist physicians in making timely treatment decisions for stroke patients.

DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.

PhoreMost is a UK-based drug discovery company specializing in identifying new druggable targets for cancer and other diseases. Established in 2014, it develops Site-Seeker, a platform that systematically uncovers druggable sites in the human genome and links them to useful therapeutic functions in live cells.

Echopoint Medical Ltd, established in 2018 and headquartered in London, specializes in developing medical devices that incorporate optical-fibre based sensors. The company leverages optical fibre sensing technologies to enhance precision and efficacy in invasive cardiology and other minimally invasive procedures, with a focus on transforming the diagnosis and treatment of cardiovascular diseases.

Nu Quantum is a Cambridge-based quantum technology company developing the networking infrastructure required to scale quantum computers. It produces quantum photonics hardware, including photon sources and detectors, and nano-engineered materials for quantum light generation and ultra-sensitive detection. The firm is building a complete hardware system to create entangled qubit networks by interconnecting computing cores into large distributed clusters, featuring a high-speed network interface, photonic switching fabric, and control systems. This entangled fabric enables secure exchange of cryptographic keys and underpins quantum encryption links for sensitive communications. Partnerships with leading quantum companies, governments, and research groups support the path to market.

Phasecraft is a UK-based company founded in 2018 by world-class quantum scientists and engineers. They specialize in developing quantum software for intermediate-scale devices and quantum computers, aiming to accelerate practical applications of quantum computing.

RoboK develops innovative computer vision technology to enhance safety and efficiency in industrial workplaces. Founded in 2017, the company transforms on-site visual data from CCTV cameras into valuable actionable insights for critical infrastructure operators.

PharmEnable Limited is a drug discovery company based in Cambridge, United Kingdom, that specializes in the design of small molecule drugs through the integration of medicinal chemistry and artificial intelligence computational methods. Established in 2016, the company has created a rapid and cost-effective approach to identify superior chemical starting points, thereby facilitating the discovery of essential new medicines.

DefiniGEN specializes in providing human cell products for life science and drug discovery sectors. Its offerings include specialized hepatocytes and pancreatic cells for predictive toxicology, diabetes research, and disease modeling. The company serves pharmaceutical companies by offering custom cell production services and contract services such as Def-PANC diabetes compound profiling.

Founded in 2018, Xampla develops plant-based materials derived from pea protein to replace microplastics. Its product range includes microcapsules for homecare and personal care products, films, coatings, and single-use plastics for packaging applications.

AccelerComm is a semiconductor IP-core company that provides forward error correction and channel coding solutions for wireless communications. It develops hardware-friendly encoders and decoders, including 3GPP-compliant encoding/decoding chains, turbo decoders, LDPC chains, and polar encoder/decoder facilities, to accelerate next-generation wireless systems and overcome bottlenecks in error correction decoding caused by noise and interference. The company focuses on patent-pending channel coding technology that enhances data throughput and efficiency for 3GPP-based networks and related applications, including base stations and mobile devices. Headquartered in Southampton, United Kingdom, AccelerComm aims to enable cost-effective, high-performance digital communications across multiple standards.

LettUs Grow develops aeroponic irrigation and farm management technology for greenhouse and vertical farming. The company designs modular, nozzle-free aeroponic systems that deliver nutrient mist to plant roots and are paired with automated control software to optimize conditions for individual species, while enabling pesticide-free operation. Its hardware and software aim to reduce labor, improve efficiency, and lower costs, with environmental benefits such as reduced waste and carbon footprint. Founded in 2015 and based in Bristol, United Kingdom, LettUs Grow markets solutions that support sustainable indoor farming.

Mind Foundry Limited, incorporated in 2015 and based in Oxford, United Kingdom, develops enterprise software that enables organizations to extract valuable insights from their data. As an Oxford University company founded by leading experts in artificial intelligence and machine learning, Mind Foundry focuses on creating Responsible AI solutions designed to address significant real-world challenges across various sectors, including insurance, infrastructure, and defense. Their AI platform leverages advanced machine learning and algorithmic modeling techniques to help organizations tackle issues such as insurance fraud detection and complex signal processing. By promoting the responsible and transparent use of AI, Mind Foundry aims to foster collaboration between humans and artificial intelligence to address pressing global problems.

Symetrica Ltd. is a company that specializes in the development and commercialization of integrated radiation detection and identification technologies. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, Symetrica serves various sectors including military, homeland security, medical diagnostics, geophysical, and space research. The company produces a range of advanced devices, such as handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, which utilize machine learning to enhance operational effectiveness for security teams. These systems are employed by customs and border protection, law enforcement, military, and emergency services around the world, enabling them to identify threats and respond efficiently.

Founded in 2016, Qkine is a biotechnology company based in Cambridge, UK. It specializes in manufacturing high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell culture, organoid research, and regenerative medicine.

DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.

Opsydia Limited, established in 2017 and based in Begbroke, UK, specializes in manufacturing advanced laser marking technology. This technology enables the creation of permanent, invisible structures such as serial numbers, images, and cryptographic data within transparent materials like diamonds, glass, polymers, and plastics without altering their surface or integrity. Opsydia's innovative solution aims to disrupt various industries by enhancing security, traceability, and authenticity in transparent materials.

Crypto Quantique develops quantum-driven security solutions for connected devices by designing a secure chip on silicon that uses quantum processes to generate cryptographic keys. The chip can be integrated into new devices or retrofitted into existing ones, enabling multiple applications to operate with unique, unforgeable keys that do not need to be stored. The company combines cryptography and quantum physics in a platform that delivers hardware and software products for future-proof cybersecurity, with a focus on protecting local networks and IoT environments through end-to-end security in a scalable manner. Founded in 2015 and based in London, Crypto Quantique aims to provide robust protection for the Internet of Things by enabling on-demand cryptographic operations and key management.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.

Concr is a mission-driven techbio company that uses established methods from astrophysics to predict patient outcomes and treatment response to cancer therapies. The approach enables iterative learning from fragmented data across the drug development and clinical journey, producing accurate multi-modal tumor models without relying on large, homogeneous datasets. Its cloud-native platform FarrSight supports computational simulation of clinical trials, prediction of therapeutic response and biomarkers, and standard bioinformatics analyses. Headquartered in London with a wholly owned subsidiary in Brisbane, Concr provides a cloud-based system that identifies optimal treatments for individuals, reduces resistance, and offers patient-specific progression insights and evidence-based treatment plans to guide proactive therapy.

Ceryx Medical Limited is a biotechnology company based in Bath, United Kingdom, founded in 2016. The company specializes in developing and manufacturing innovative bio-electronic devices that utilize unique, patent-protected chip technology. These devices are designed to mimic Central Pattern Generators (CPGs), which are nerve centers in the body responsible for regulating various autonomic and rhythmical processes, including peristalsis, heart rate, and walking. Ceryx Medical aims to restore normal physiological functions that may be compromised due to disease or injury by employing artificial CPGs in their therapeutic devices.

GripAble Ltd. is a London-based company founded in 2017 that specializes in the development of digital therapy devices aimed at improving rehabilitation for individuals with movement impairments. The company’s flagship product, the GripAble Digital Handgrip, is a sensitive, portable device that wirelessly connects to a mobile application. This app allows users to engage in interactive therapy games designed to facilitate the assessment and training of hand and arm functions. GripAble's solutions target patients suffering from conditions such as stroke, arthritis, cerebral palsy, and trauma, addressing the challenges faced by over 500 million people globally who experience impaired arm mobility. By combining hardware with gamified therapy, GripAble enhances patient engagement and enables effective self-training both in clinical settings and at home.

Sano Genetics is a health technology company that operates a user-centered genetic data-sharing platform. The platform enables researchers to analyze data provided with user consent and to recruit for studies and clinical trials based on participants’ genetic and health information. It provides access to research on genetics and genetic diseases and supports programs that study the genetics of various human traits. The company connects individuals with researchers through its platform, supporting both common and rare disease research and enabling dynamic, health and genetic data sets to advance personalized medicine. Founded in 2017 and based in Cambridge, United Kingdom, Sano Genetics aims to empower participants to contribute their genetic and health data to scientific studies, facilitating collaboration and enabling new approaches to diagnosis and treatment.

BibliU operates a digital platform that provides colleges and universities with managed access to millions of textbooks and academic resources. It offers automation tools, analytics, and offline support, enhancing student learning efficiency.

Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.

Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.

Orthox Ltd. is a medical implant company based in Abingdon, United Kingdom, that specializes in developing tissue regenerative implants for knee cartilage injuries. Founded to commercialize technology from Oxford University, Orthox aims to transform the treatment of cartilage damage, addressing the needs of over 300 million patients worldwide affected by osteoarthritis. The company's flagship product, FibroFix, is a hydrogel implant designed to emulate human knee cartilage, enabling effective repair and regeneration of damaged tissues. Orthox offers several variations of FibroFix, including FibroFix Meniscus for meniscal cartilage repair and FibroFix Cartilage for articular cartilage damage. The implants promote integration with the body's cells, facilitating a return to active, pain-free living. With plans to expand its technology to other joints and additional applications beyond orthopaedics, Orthox is positioned to capitalize on the rapidly growing biomaterials market, projected to exceed $250 billion by 2025.

Sano Genetics is a health technology company that operates a user-centered genetic data-sharing platform. The platform enables researchers to analyze data provided with user consent and to recruit for studies and clinical trials based on participants’ genetic and health information. It provides access to research on genetics and genetic diseases and supports programs that study the genetics of various human traits. The company connects individuals with researchers through its platform, supporting both common and rare disease research and enabling dynamic, health and genetic data sets to advance personalized medicine. Founded in 2017 and based in Cambridge, United Kingdom, Sano Genetics aims to empower participants to contribute their genetic and health data to scientific studies, facilitating collaboration and enabling new approaches to diagnosis and treatment.

Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.

DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.

Brainomix develops AI-powered imaging biomarkers for neurological and cerebrovascular disorders. Its software suite, including e-ASPECTS, e-CTA, and e-Mismatch, automates brain scan analysis to assist physicians in making timely treatment decisions for stroke patients.

PetMedix Ltd is a veterinary biopharmaceutical company based in Hinxton, United Kingdom, that specializes in therapeutic drug discovery for pets. Founded in 2017, the company utilizes advanced scientific techniques to develop innovative antibody therapies aimed at improving the health and well-being of companion animals. PetMedix has created specialized platforms, including the Ky9 and Felyne transgenic mouse systems, which are designed to produce therapeutic-quality antibodies tailored for pets. This approach allows for the generation of a diverse repertoire of antibodies that mirrors the immune systems of companion animals, enabling veterinarians to administer safe and effective monoclonal antibody treatments. By applying over thirty years of expertise in human drug development to veterinary medicine, PetMedix is dedicated to enhancing the quality of life for pets through cutting-edge therapies.

Founded in 2020, Nyobolt is a UK-based company specializing in advanced battery technology for automotive applications. It focuses on developing high-power, fast-charging batteries with large energy storage capacity.

Echion Technologies, founded in 2017 and based in Cambridge, United Kingdom, specializes in developing advanced anode materials for lithium-ion (Li-ion) batteries. Their proprietary XNO® material offers faster charging times, longer lifespans, and improved safety compared to traditional options. The company targets the heavy-duty electric vehicle market, aiming to enhance efficiency and sustainability within the transportation sector by providing optimized power anode materials for cost-effective battery production.

Bonnet Ltd. is a London-based company established in 2019 that specializes in charging-as-a-service solutions for electric vehicle drivers. Its platform simplifies the charging experience by enabling users to access a wide network of public chargers through a single application, eliminating the need for separate registrations with individual charging networks. By streamlining the process, Bonnet aims to enhance convenience for both drivers and businesses, facilitating easier and more efficient electric vehicle charging.

PredictImmune Ltd is a biotechnology company based in Cambridge, United Kingdom, focused on developing prognostic tests for immune-mediated inflammatory diseases. Established in 2017, the company offers PredictSURE IBD, a diagnostic tool designed to identify patients with Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis, who are at risk of severe, relapsing disease. This simple lab test requires only a small blood sample and provides critical insights that enable healthcare providers to tailor early biologic therapies for at-risk patients. By delivering personalized treatment options, PredictImmune aims to improve disease management and clinical outcomes for individuals suffering from IBD, addressing an important need recognized by physicians, patients, and payors alike.

GripAble Ltd. is a London-based company founded in 2017 that specializes in the development of digital therapy devices aimed at improving rehabilitation for individuals with movement impairments. The company’s flagship product, the GripAble Digital Handgrip, is a sensitive, portable device that wirelessly connects to a mobile application. This app allows users to engage in interactive therapy games designed to facilitate the assessment and training of hand and arm functions. GripAble's solutions target patients suffering from conditions such as stroke, arthritis, cerebral palsy, and trauma, addressing the challenges faced by over 500 million people globally who experience impaired arm mobility. By combining hardware with gamified therapy, GripAble enhances patient engagement and enables effective self-training both in clinical settings and at home.

PhoreMost is a UK-based drug discovery company specializing in identifying new druggable targets for cancer and other diseases. Established in 2014, it develops Site-Seeker, a platform that systematically uncovers druggable sites in the human genome and links them to useful therapeutic functions in live cells.

Mirriad Advertising, established in 2015 and headquartered in London, specializes in in-video advertising solutions. It uses artificial intelligence and computer vision technology to dynamically insert products and signage into existing video content, creating new advertising inventory for content producers and distributors. This approach enhances viewer engagement and limits commercial interruptions. Mirriad serves clients in the UK, US, China, and other countries, generating the majority of its revenue in the US.

Phasecraft is a UK-based company founded in 2018 by world-class quantum scientists and engineers. They specialize in developing quantum software for intermediate-scale devices and quantum computers, aiming to accelerate practical applications of quantum computing.

Congenica Ltd. is a biotechnology company that specializes in clinical data solutions for genetic diagnosis. Established in 2012 and headquartered in Hinxton, United Kingdom, it offers the Sapientia platform, a clinical genomic analytics tool that integrates human DNA sequences with deep clinical phenotyping. This platform enables clinicians and researchers to interpret genetic diseases and provides actionable insights for diagnosis, prognosis, and research. Additionally, Sapientia supports personalized medicine by facilitating the creation of disease registries, identifying patient populations for clinical studies, and aiding in the discovery of novel drug targets and biomarkers. Congenica's focus is on improving clinical outcomes through advanced genomic analysis.

1715 Labs Ltd specializes in data labeling services powered by artificial intelligence. Founded in 2018 and located in Oxford, United Kingdom, the company offers a range of solutions in computer vision and language processing. Its computer vision capabilities include image categorization and various forms of segmentation, while its language processing services encompass text classification, relationship identification, and sentiment recognition, among others. By combining human expertise with advanced statistical tools, 1715 Labs aims to provide organizations with rapid and cost-effective data training, labeling, and analysis, ultimately assisting businesses in effectively utilizing their data. Additionally, 1715 Labs is focused on commercializing Zooniverse technology to expand its offerings in the data labeling market.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.

GeoSpock Limited, established in 2013 and headquartered in Cambridge, UK, with offices in Tokyo and Singapore, specializes in developing a unique, cloud-native database platform, GeoSpock DB. This platform is optimized for querying and analyzing large-scale, location-tagged data, enabling efficient data fusion and rapid, complex queries using SQL. It integrates seamlessly with popular business intelligence tools and data science environments, empowering users to unlock insights from diverse IoT data sources, from real-time fleet tracking to local service applications.

Founded in 2020, Nyobolt is a UK-based company specializing in advanced battery technology for automotive applications. It focuses on developing high-power, fast-charging batteries with large energy storage capacity.

Ceryx Medical Limited is a biotechnology company based in Bath, United Kingdom, founded in 2016. The company specializes in developing and manufacturing innovative bio-electronic devices that utilize unique, patent-protected chip technology. These devices are designed to mimic Central Pattern Generators (CPGs), which are nerve centers in the body responsible for regulating various autonomic and rhythmical processes, including peristalsis, heart rate, and walking. Ceryx Medical aims to restore normal physiological functions that may be compromised due to disease or injury by employing artificial CPGs in their therapeutic devices.

Nu Quantum is a Cambridge-based quantum technology company developing the networking infrastructure required to scale quantum computers. It produces quantum photonics hardware, including photon sources and detectors, and nano-engineered materials for quantum light generation and ultra-sensitive detection. The firm is building a complete hardware system to create entangled qubit networks by interconnecting computing cores into large distributed clusters, featuring a high-speed network interface, photonic switching fabric, and control systems. This entangled fabric enables secure exchange of cryptographic keys and underpins quantum encryption links for sensitive communications. Partnerships with leading quantum companies, governments, and research groups support the path to market.

GaitQ Limited is a medical device company founded in 2019 and based in Oxfordshire, United Kingdom. It specializes in developing the GaitThaw device, which addresses the issue of gait freezing in individuals with Parkinson's disease. This small and portable device employs clinically proven sensory cues to assist patients in re-establishing the connection between the brain and body, thereby facilitating smoother walking. GaitQ aims to improve mobility and enhance the quality of life for those affected by this debilitating symptom of Parkinson's disease.

Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.

Symetrica Ltd. is a company that specializes in the development and commercialization of integrated radiation detection and identification technologies. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, Symetrica serves various sectors including military, homeland security, medical diagnostics, geophysical, and space research. The company produces a range of advanced devices, such as handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, which utilize machine learning to enhance operational effectiveness for security teams. These systems are employed by customs and border protection, law enforcement, military, and emergency services around the world, enabling them to identify threats and respond efficiently.

Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.

Ceryx Medical Limited is a biotechnology company based in Bath, United Kingdom, founded in 2016. The company specializes in developing and manufacturing innovative bio-electronic devices that utilize unique, patent-protected chip technology. These devices are designed to mimic Central Pattern Generators (CPGs), which are nerve centers in the body responsible for regulating various autonomic and rhythmical processes, including peristalsis, heart rate, and walking. Ceryx Medical aims to restore normal physiological functions that may be compromised due to disease or injury by employing artificial CPGs in their therapeutic devices.

Mind Foundry Limited, incorporated in 2015 and based in Oxford, United Kingdom, develops enterprise software that enables organizations to extract valuable insights from their data. As an Oxford University company founded by leading experts in artificial intelligence and machine learning, Mind Foundry focuses on creating Responsible AI solutions designed to address significant real-world challenges across various sectors, including insurance, infrastructure, and defense. Their AI platform leverages advanced machine learning and algorithmic modeling techniques to help organizations tackle issues such as insurance fraud detection and complex signal processing. By promoting the responsible and transparent use of AI, Mind Foundry aims to foster collaboration between humans and artificial intelligence to address pressing global problems.

Symetrica Ltd. is a company that specializes in the development and commercialization of integrated radiation detection and identification technologies. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, Symetrica serves various sectors including military, homeland security, medical diagnostics, geophysical, and space research. The company produces a range of advanced devices, such as handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, which utilize machine learning to enhance operational effectiveness for security teams. These systems are employed by customs and border protection, law enforcement, military, and emergency services around the world, enabling them to identify threats and respond efficiently.

Founded in 2016, Qkine is a biotechnology company based in Cambridge, UK. It specializes in manufacturing high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell culture, organoid research, and regenerative medicine.

Oxford Flow designs, manufactures, and supplies pressure control equipment, including gas and fluid pressure regulators, water PRVs, silencers, and pilots, serving water, gas, marine, oil and gas, process, power, building services, and specialty applications. The company develops small, light, and reliable conventional valves that simplify systems and ensure continual potable water supplies while meeting standards for water quality and leakage control. It combines academic and industry expertise to develop practical, rigorously tested solutions that perform under harsh conditions, aiming to reduce total cost of ownership and environmental impact while improving reliability and energy efficiency. Based in Oxford, United Kingdom.

Flusso Ltd, established in 2016 and headquartered in Cambridge, United Kingdom, specializes in the development and manufacturing of sensor solutions tailored to various industries. The company produces mass flow and air velocity sensors, leveraging proprietary technology to meet specific application needs.

Sorex Sensors designs and manufactures high-sensitivity micro-electro-mechanical system (MEMS) mass sensors based on film bulk acoustic resonator (FBAR) technology. Their products, fabricated on silicon wafers, measure mass down to the femtogram range and temperature with a resolution of 0.2°C, making them suitable for thin film metrology, particulate monitoring, and gas detection applications.

Founded in 2018, Xampla develops plant-based materials derived from pea protein to replace microplastics. Its product range includes microcapsules for homecare and personal care products, films, coatings, and single-use plastics for packaging applications.

PharmEnable Limited is a drug discovery company based in Cambridge, United Kingdom, that specializes in the design of small molecule drugs through the integration of medicinal chemistry and artificial intelligence computational methods. Established in 2016, the company has created a rapid and cost-effective approach to identify superior chemical starting points, thereby facilitating the discovery of essential new medicines.

Ilika specializes in accelerating material development for energy and electronics applications using proprietary high-throughput techniques. Its solid-state battery technology powers miniature medical devices, industrial IoT, electric vehicles, and consumer electronics across Asia, Europe, North America, and the UK.

Echion Technologies, founded in 2017 and based in Cambridge, United Kingdom, specializes in developing advanced anode materials for lithium-ion (Li-ion) batteries. Their proprietary XNO® material offers faster charging times, longer lifespans, and improved safety compared to traditional options. The company targets the heavy-duty electric vehicle market, aiming to enhance efficiency and sustainability within the transportation sector by providing optimized power anode materials for cost-effective battery production.

RoboK develops innovative computer vision technology to enhance safety and efficiency in industrial workplaces. Founded in 2017, the company transforms on-site visual data from CCTV cameras into valuable actionable insights for critical infrastructure operators.

Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.

LettUs Grow develops aeroponic irrigation and farm management technology for greenhouse and vertical farming. The company designs modular, nozzle-free aeroponic systems that deliver nutrient mist to plant roots and are paired with automated control software to optimize conditions for individual species, while enabling pesticide-free operation. Its hardware and software aim to reduce labor, improve efficiency, and lower costs, with environmental benefits such as reduced waste and carbon footprint. Founded in 2015 and based in Bristol, United Kingdom, LettUs Grow markets solutions that support sustainable indoor farming.

Covatic develops broadcast personalization software and a consumer insights platform that enables on-device personalization for applications. Incorporated in 2016, the company is based in Birmingham, United Kingdom, with an additional office in London. Its platform provides an on-device software development kit that leverages trusted first-party and offline consented data to create contextual audience segments, helping media companies deliver relevant advertising while strengthening user trust and complying with privacy regulations.

Echopoint Medical Ltd, established in 2018 and headquartered in London, specializes in developing medical devices that incorporate optical-fibre based sensors. The company leverages optical fibre sensing technologies to enhance precision and efficacy in invasive cardiology and other minimally invasive procedures, with a focus on transforming the diagnosis and treatment of cardiovascular diseases.

Undo Ltd., established in 2005, specializes in developing debugging tools for software developers. Its flagship product, LiveRecorder, records and replays software execution to aid in identifying and fixing programming errors. UndoDB, another key offering, provides an interactive reversible debugger for C/C++ on Linux and Android platforms. The company serves industries such as data management, networking, electronic design automation, and finance, with offices in Cambridge, UK, and San Francisco, CA.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.

Mirriad Advertising, established in 2015 and headquartered in London, specializes in in-video advertising solutions. It uses artificial intelligence and computer vision technology to dynamically insert products and signage into existing video content, creating new advertising inventory for content producers and distributors. This approach enhances viewer engagement and limits commercial interruptions. Mirriad serves clients in the UK, US, China, and other countries, generating the majority of its revenue in the US.

PredictImmune Ltd is a biotechnology company based in Cambridge, United Kingdom, focused on developing prognostic tests for immune-mediated inflammatory diseases. Established in 2017, the company offers PredictSURE IBD, a diagnostic tool designed to identify patients with Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis, who are at risk of severe, relapsing disease. This simple lab test requires only a small blood sample and provides critical insights that enable healthcare providers to tailor early biologic therapies for at-risk patients. By delivering personalized treatment options, PredictImmune aims to improve disease management and clinical outcomes for individuals suffering from IBD, addressing an important need recognized by physicians, patients, and payors alike.

Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.

Symetrica Ltd. is a company that specializes in the development and commercialization of integrated radiation detection and identification technologies. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, Symetrica serves various sectors including military, homeland security, medical diagnostics, geophysical, and space research. The company produces a range of advanced devices, such as handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, which utilize machine learning to enhance operational effectiveness for security teams. These systems are employed by customs and border protection, law enforcement, military, and emergency services around the world, enabling them to identify threats and respond efficiently.

Founded in 2016, Qkine is a biotechnology company based in Cambridge, UK. It specializes in manufacturing high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell culture, organoid research, and regenerative medicine.

Inductosense is a technology company developing wireless, battery-free sensors that can be permanently attached to structures or products to enable fast, repeatable inspections for cracks, corrosion, and other defects. Its Wireless And Non Destructive (WAND) system uses passive sensors that are powered and read non-contact via inductive coupling from a handheld probe, allowing sensing under coatings, insulation, or repairs and even embedding within materials. The company offers easy-to-install sensors, measurement probes, and data collection or remote monitoring capabilities to monitor internal corrosion and erosion in pipes and vessels at elevated temperatures. Applications include inspection of large structures, composites repair, remote monitoring, and under coatings. Founded in 2015 and based in Bristol, the United Kingdom, the company aims to improve inspection efficiency, reduce costs, and enhance safety by enabling long-term, non-destructive evaluation through continuous monitoring.

PolyProx Therapeutics Ltd is a biotechnology company based in Cambridge, United Kingdom, founded in 2018. It focuses on researching and developing innovative drug therapies aimed at treating cancer and neurodegenerative diseases. The company's flagship product, Polyproxin, utilizes engineered proteins that selectively target tumor cells. This mechanism activates the natural degradation processes within the cells, allowing for the removal of disease-causing proteins. By employing this novel approach, PolyProx aims to provide effective treatment options for cancer patients, potentially improving their outcomes and quality of life.

Congenica Ltd. is a biotechnology company that specializes in clinical data solutions for genetic diagnosis. Established in 2012 and headquartered in Hinxton, United Kingdom, it offers the Sapientia platform, a clinical genomic analytics tool that integrates human DNA sequences with deep clinical phenotyping. This platform enables clinicians and researchers to interpret genetic diseases and provides actionable insights for diagnosis, prognosis, and research. Additionally, Sapientia supports personalized medicine by facilitating the creation of disease registries, identifying patient populations for clinical studies, and aiding in the discovery of novel drug targets and biomarkers. Congenica's focus is on improving clinical outcomes through advanced genomic analysis.

Cytora provides a configurable risk digitization and analytics platform for commercial insurance. The platform digitizes each incoming risk, augments it with internal and external data sources, and evaluates it against rules governing appetite and priority before routing to downstream underwriting systems for automated or manual processing. Using artificial intelligence, Cytora learns patterns of risk and loss outcomes over time, computes a risk rank, score, and price for each property and organization, and helps insurers target profitable risks, improve risk selection, and optimize pricing. The company was founded in 2014 and is headquartered in London.

Founded in 2012, Aqdot specializes in innovative microencapsulation technology. Its patented one-step shrink-wrap approach combines emulsion technology and supramolecular chemistry to create smart microcapsules with customizable properties. This energy-efficient manufacturing process serves various industries, including household care, agrochemicals, and food sectors.

Perpetuum Ltd. is a company based in Southampton, United Kingdom, that specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 as a technology spin-off from the University of Southampton, Perpetuum has developed innovative self-powered wireless sensor solutions designed for condition monitoring in various industries, including rail, oil and gas, chemicals, and power generation. Its flagship products convert mechanical vibration into electrical energy, allowing for the operation of autonomous, maintenance-free wireless sensor nodes that transmit critical data on equipment health and performance. Perpetuum is recognized as the global leader in vibration energy harvesting, continually advancing the practical applications of this technology to enhance operational efficiency and safety in industrial environments.

GeoSpock Limited, established in 2013 and headquartered in Cambridge, UK, with offices in Tokyo and Singapore, specializes in developing a unique, cloud-native database platform, GeoSpock DB. This platform is optimized for querying and analyzing large-scale, location-tagged data, enabling efficient data fusion and rapid, complex queries using SQL. It integrates seamlessly with popular business intelligence tools and data science environments, empowering users to unlock insights from diverse IoT data sources, from real-time fleet tracking to local service applications.

Phasecraft is a UK-based company founded in 2018 by world-class quantum scientists and engineers. They specialize in developing quantum software for intermediate-scale devices and quantum computers, aiming to accelerate practical applications of quantum computing.

Mind Foundry Limited, incorporated in 2015 and based in Oxford, United Kingdom, develops enterprise software that enables organizations to extract valuable insights from their data. As an Oxford University company founded by leading experts in artificial intelligence and machine learning, Mind Foundry focuses on creating Responsible AI solutions designed to address significant real-world challenges across various sectors, including insurance, infrastructure, and defense. Their AI platform leverages advanced machine learning and algorithmic modeling techniques to help organizations tackle issues such as insurance fraud detection and complex signal processing. By promoting the responsible and transparent use of AI, Mind Foundry aims to foster collaboration between humans and artificial intelligence to address pressing global problems.

PetMedix Ltd is a veterinary biopharmaceutical company based in Hinxton, United Kingdom, that specializes in therapeutic drug discovery for pets. Founded in 2017, the company utilizes advanced scientific techniques to develop innovative antibody therapies aimed at improving the health and well-being of companion animals. PetMedix has created specialized platforms, including the Ky9 and Felyne transgenic mouse systems, which are designed to produce therapeutic-quality antibodies tailored for pets. This approach allows for the generation of a diverse repertoire of antibodies that mirrors the immune systems of companion animals, enabling veterinarians to administer safe and effective monoclonal antibody treatments. By applying over thirty years of expertise in human drug development to veterinary medicine, PetMedix is dedicated to enhancing the quality of life for pets through cutting-edge therapies.

Flusso Ltd, established in 2016 and headquartered in Cambridge, United Kingdom, specializes in the development and manufacturing of sensor solutions tailored to various industries. The company produces mass flow and air velocity sensors, leveraging proprietary technology to meet specific application needs.

GeoSpock Limited, established in 2013 and headquartered in Cambridge, UK, with offices in Tokyo and Singapore, specializes in developing a unique, cloud-native database platform, GeoSpock DB. This platform is optimized for querying and analyzing large-scale, location-tagged data, enabling efficient data fusion and rapid, complex queries using SQL. It integrates seamlessly with popular business intelligence tools and data science environments, empowering users to unlock insights from diverse IoT data sources, from real-time fleet tracking to local service applications.

Echion Technologies, founded in 2017 and based in Cambridge, United Kingdom, specializes in developing advanced anode materials for lithium-ion (Li-ion) batteries. Their proprietary XNO® material offers faster charging times, longer lifespans, and improved safety compared to traditional options. The company targets the heavy-duty electric vehicle market, aiming to enhance efficiency and sustainability within the transportation sector by providing optimized power anode materials for cost-effective battery production.

Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.

Undo Ltd., established in 2005, specializes in developing debugging tools for software developers. Its flagship product, LiveRecorder, records and replays software execution to aid in identifying and fixing programming errors. UndoDB, another key offering, provides an interactive reversible debugger for C/C++ on Linux and Android platforms. The company serves industries such as data management, networking, electronic design automation, and finance, with offices in Cambridge, UK, and San Francisco, CA.

Opsydia Limited, established in 2017 and based in Begbroke, UK, specializes in manufacturing advanced laser marking technology. This technology enables the creation of permanent, invisible structures such as serial numbers, images, and cryptographic data within transparent materials like diamonds, glass, polymers, and plastics without altering their surface or integrity. Opsydia's innovative solution aims to disrupt various industries by enhancing security, traceability, and authenticity in transparent materials.

PhoreMost is a UK-based drug discovery company specializing in identifying new druggable targets for cancer and other diseases. Established in 2014, it develops Site-Seeker, a platform that systematically uncovers druggable sites in the human genome and links them to useful therapeutic functions in live cells.

Salunda develops robust contactless sensors for use in harsh environments. Its technology detects position and speed and measures fluid composition, enabling inline water cut and multiphase flow sensing for oil, water, and gas fractions, as well as downhole inspection tools and BHA sensors to detect wear and potential failure. The sensors scan components such as pistons, rotors and seals for wear, and can warn of imminent issues by identifying cracks, eccentric motion, orbiting, axial shift, or vibration. The system includes oilfield tooling, production and test separator level sensing in the presence of bubbles and froth, and handheld testers for detecting biofuel in diesel. The company also supplies sensor probes and electronics that measure fluid levels and monitor froth and entrained gases, with self-compensation for changing fluid characteristics and temperature. OEM components support open-bore water cut and multiphase flow applications, and the technology is suitable for intrinsic safety and offshore environments.

Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.

Oxford Flow designs, manufactures, and supplies pressure control equipment, including gas and fluid pressure regulators, water PRVs, silencers, and pilots, serving water, gas, marine, oil and gas, process, power, building services, and specialty applications. The company develops small, light, and reliable conventional valves that simplify systems and ensure continual potable water supplies while meeting standards for water quality and leakage control. It combines academic and industry expertise to develop practical, rigorously tested solutions that perform under harsh conditions, aiming to reduce total cost of ownership and environmental impact while improving reliability and energy efficiency. Based in Oxford, United Kingdom.

Brainomix develops AI-powered imaging biomarkers for neurological and cerebrovascular disorders. Its software suite, including e-ASPECTS, e-CTA, and e-Mismatch, automates brain scan analysis to assist physicians in making timely treatment decisions for stroke patients.

OxSyBio Ltd. is a biotechnology company based in London, United Kingdom, specializing in the development of advanced 3D printing techniques for creating tissue-like and functional tissues intended for medical research and clinical applications. Founded in 2014, the company focuses on innovative methods that utilize three-dimensional networks of lipid monolayer aqueous droplets, which can conduct electrical signals along designated pathways and self-fold into intricate structures. These engineered tissues aim to facilitate organ repair or replacement, supporting precision medicine initiatives. The technology builds upon pioneering research from Professor Hagan Bayley's group at the University of Oxford, emphasizing the integration of chemical and synthetic biology in the field of regenerative medicine.

GeoSpock Limited, established in 2013 and headquartered in Cambridge, UK, with offices in Tokyo and Singapore, specializes in developing a unique, cloud-native database platform, GeoSpock DB. This platform is optimized for querying and analyzing large-scale, location-tagged data, enabling efficient data fusion and rapid, complex queries using SQL. It integrates seamlessly with popular business intelligence tools and data science environments, empowering users to unlock insights from diverse IoT data sources, from real-time fleet tracking to local service applications.

Bodle Technologies, established in 2015 and based in Begbroke, UK, specializes in advanced optoelectronic solutions for displays and smart windows. The company's core product is its proprietary SRD® technology, the world's first solid-state reflective display, which offers ultra-high resolution, vivid color, and video capability with zero energy use for static image storage. This bi-stable reflective display is ideal for wearables, near-eye, and projection-based displays, providing a more natural viewing experience, particularly in outdoor conditions. Additionally, Bodle Technologies develops security coatings that change color under various probing techniques, ensuring unbreakable security features in currencies, ID cards, and official documentation.

Cytora provides a configurable risk digitization and analytics platform for commercial insurance. The platform digitizes each incoming risk, augments it with internal and external data sources, and evaluates it against rules governing appetite and priority before routing to downstream underwriting systems for automated or manual processing. Using artificial intelligence, Cytora learns patterns of risk and loss outcomes over time, computes a risk rank, score, and price for each property and organization, and helps insurers target profitable risks, improve risk selection, and optimize pricing. The company was founded in 2014 and is headquartered in London.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.